Varex Imaging (NASDAQ:VREX - Get Free Report) updated its second quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.050-0.200 for the period, compared to the consensus estimate of 0.120. The company issued revenue guidance of $200.0 million-$215.0 million, compared to the consensus revenue estimate of $201.6 million.
Varex Imaging Stock Performance
Shares of VREX stock traded up $0.69 on Monday, reaching $12.96. The stock had a trading volume of 986,161 shares, compared to its average volume of 500,086. The stock has a market cap of $534.35 million, a P/E ratio of -11.08 and a beta of 0.62. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.97 and a current ratio of 3.32. Varex Imaging has a 1 year low of $10.19 and a 1 year high of $18.30. The company has a 50 day simple moving average of $14.45 and a 200 day simple moving average of $13.36.
Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 3.96% and a negative net margin of 5.79%. Equities research analysts expect that Varex Imaging will post 0.63 EPS for the current year.
Wall Street Analyst Weigh In
A number of analysts have commented on VREX shares. Oppenheimer reduced their target price on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a report on Friday. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday. Finally, B. Riley reiterated a "buy" rating and set a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research report on Friday.
View Our Latest Report on Varex Imaging
Varex Imaging Company Profile
(
Get Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
See Also
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
